Italy's antitrust regulator has launched a probe into several pharmaceutical companies, including Novartis, for potentially restricting competition in the sale of a drug for eye conditions. Additionally, a federal judge has ordered an investigation into the claims distribution process of a $30 million settlement by Novartis with consumers and health plans over its hypertension drug Exforge. The judge highlighted concerns about the integrity of the process, noting that only 22,000 out of 132,000 consumer claims were approved, which he described as 'disproportionately low.'
A federal judge ordered a probe of Novartis' $30 million settlement claims distribution process, stating that out of 132,000 consumer claims submitted to the settlement administrator, just over 22,000 were allowed, which 'seems disproportionately low' https://t.co/sGaluMe5LZ https://t.co/hW2pNOq2wT
A federal judge has ordered a probe of the claims distribution process in a $30 million settlement by Novartis with consumers and health plans in an antitrust class action over its hypertension drug Exforge, citing concerns about its integrity https://t.co/LFITyMH6XX https://t.co/BdMX2bL5d7
Novartis and others face Italy antitrust probe over eye drug https://t.co/WxzB3PZF4O https://t.co/6XLUUTg5oj
Italy's antitrust regulator said on Thursday it had launched a probe into several pharmaceutical companies, including Novartis , for having potentially restricted competition in the sale of a drug for eye conditions. https://t.co/P9tV7Zp3BX https://t.co/P9tV7Zp3BX
DOJ Announces $1.3 Million Settlement Involving a Laboratory Marketer, Physicians, and the Physicians’ Medical Practices https://t.co/gesb47R92T #DOJ #falseclaimsact #antikickback @nickneral https://t.co/3rgVFMxfpy